Advertisement

Interpretation of the Chinese Clinical Guideline for Continuous Glucose Monitoring

Chapter

Abstract

In recent years, continuous glucose monitoring (CGM) has attracted more and more attention, and it has been applied in clinical practice. In order to promote the standardization of CGM in clinical application, CGM-related guidelines have been carried out and updated on a regular basis worldwide. In this chapter, we will introduce the Chinese and international clinical guidelines for CGM in recent years. First, we will review the classification of CGM and findings from evidence-based medicine and then summarize the indications for retrospective CGM and real-time CGM in Chinese and international guidelines, as well as the details in data collection and analysis in the clinical application. Then, we will discuss the problems that need to be solved in the development of CGM technology. Finally, on the basis of the Clinical Application Guide of Blood Glucose Monitoring in China (Edition 2011), we will briefly introduce the updated contents of the 2015 edition of the Guideline.

Keywords

Continuous glucose monitoring Guideline interpretation Development trend 

References

  1. 1.
    Updike SJ, Hicks GP. Reagentless substrate analysis with immobilized enzymes. Science. 1967;158:270–2.  https://doi.org/10.1126/science.158.3798.270.CrossRefPubMedGoogle Scholar
  2. 2.
    Chinese Diabetes Society. Chinese clinical guideline for continuous glucose monitoring (2009). Zhonghua Yi Xue Za Zhi. 2009;89:3388–92.  https://doi.org/10.3760/cma.j.issn.0376-2491.2009.48.002.CrossRefGoogle Scholar
  3. 3.
    Chinese Diabetes Society. Chinese clinical guideline for continuous glucose monitoring (2012). Chin Med J. 2012;125:4167–74.  https://doi.org/10.3760/cma.j.issn.0366-6999.2012.23.002.CrossRefGoogle Scholar
  4. 4.
    Chinese Diabetes Society. Clinical application guide of blood glucose monitoring in China (Edition 2011). Zhonghua Yi Xue Za Zhi. 2011;91:656–64.  https://doi.org/10.3760/cma.j.issn.0376-2491.2011.10.003.CrossRefGoogle Scholar
  5. 5.
    Chinese Diabetes Society. Clinical application guide of blood glucose monitoring in China (Edition 2015). Chin J of Diabetes Mellitus. 2015;7:603–13.  https://doi.org/10.3760/cma.j.issn.1674-5809.2015.10.004.CrossRefGoogle Scholar
  6. 6.
    Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovič L, Nardacci E, Orzeck EA, Roberts VL, Tamborlane WV, AACE Continuous Glucose Monitoring Task Force, Rothermel C. Statement by the American association of clinical endocrinologists consensus panel on continuous glucose monitoring. Endocr Pract. 2010;16:730–45.  https://doi.org/10.4158/EP.16.5.730.CrossRefPubMedGoogle Scholar
  7. 7.
    Fonseca VA, Grunberger G, Anhalt H, Bailey TS, Blevins T, Garg SK, Handelsman Y, Hirsch IB, Orzeck EA, Roberts VL, Tamborlane W, Consensus Conference Writing Committee. Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract. 2016;22:1008–21.  https://doi.org/10.4158/EP161392.CS.CrossRefPubMedGoogle Scholar
  8. 8.
    Bailey TS, Grunberger G, Bode BW, Handelsman Y, Hirsch IB, Jovanovič L, Roberts VL, Rodbard D, Tamborlane WV, Walsh J, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). American Association of Clinical Endocrinologists and American College of Endocrinology 2016 outpatient glucose monitoring consensus statement. Endocr Pract. 2016;22:231–61.  https://doi.org/10.4158/EP151124.CS.CrossRefPubMedGoogle Scholar
  9. 9.
    Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H, Endocrine Society. Continuous glucose monitoring: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:2968–79.  https://doi.org/10.1210/jc.2010-2756.CrossRefPubMedGoogle Scholar
  10. 10.
    Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, Winter WE, Wolpert H. Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:3922–37.  https://doi.org/10.1210/jc.2016-2534.CrossRefPubMedGoogle Scholar
  11. 11.
    Vigersky R, Shrivastav M. Role of continuous glucose monitoring for type 2 in diabetes management and research. J Diabetes Complicat. 2017;31:280–7.  https://doi.org/10.1016/j.jdiacomp.2016.10.007.CrossRefPubMedGoogle Scholar
  12. 12.
    Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11(Suppl 1):55–67.  https://doi.org/10.1089/dia.2008.0132.CrossRefGoogle Scholar
  13. 13.
    Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.  https://doi.org/10.1056/NEJM199309303291401.CrossRefGoogle Scholar
  14. 14.
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.  https://doi.org/10.1016/S0140-6736(98)07019-6CrossRefGoogle Scholar
  15. 15.
    Bao Y, Ma X, Li H, Zhou M, Hu C, Wu H, Tang J, Hou X, Xiang K, Jia W. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ. 2010;340:c2249.  https://doi.org/10.1136/bmj.c2249.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Wu S, Yi F, Zhou C, Zhang M, Zhu Y, Tuniyazi Y, Huang L, Huang X, Wang F, Bi Y, Ning G. HbA1c and the diagnosis of diabetes and prediabetes in a middle-aged and elderly Han population from northwest China (HbA1c). J Diabetes. 2013;5:282–90.  https://doi.org/10.1111/1753-0407.12035.CrossRefPubMedGoogle Scholar
  17. 17.
    Wang F, Ma X, Hao Y, Yang R, Ni J, Xiao Y, Tang J, Bao Y, Jia W. Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance. PLoS One. 2012;7:e51098.  https://doi.org/10.1371/journal.pone.0051098.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Liu L, Wan X, Liu J, Huang Z, Cao X, Li Y. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy. Diabetes Technol Ther. 2012;14:756–61.  https://doi.org/10.1089/dia.2012.0055.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and Shanghai Scientific and Technical Publishers 2018

Authors and Affiliations

  1. 1.Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes InstituteShanghai Jiao Tong University, Affiliated Sixth People’s HospitalShanghaiChina

Personalised recommendations